S100A9 is not essential for disease expression in an acute (K/BxN) or chronic (CIA) model of inflammatory arthritis

R R Rampersad1, D Esserman, M W McGinnis

  • 1Thurston Arthritis Research Center, University of North Carolina School of Medicine, Division of Rheumatology, Allergy, and Immunology, Chapel Hill, NC 27599, USA.

Insights

S100A8 and S100A9 proteins are not essential for developing inflammatory arthritis in mouse models. Studies using K/BxN serum transfer and collagen-induced arthritis models showed no difference in disease severity without S100A9.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • S100A8 and S100A9 are calcium-binding proteins involved in inflammatory diseases.
  • Elevated S100A8/S100A9 levels are observed in autoimmune diseases like rheumatoid arthritis (RA).

Purpose of the Study:

  • To investigate the role of S100A8 and S100A9 in the pathogenesis of inflammatory arthritis.
  • To determine if S100A9 deficiency affects arthritis development in mouse models.

Main Methods:

  • Utilized S100A9 knockout (S100A9 - /-) and wild-type mice.
  • Induced arthritis using K/BxN serum transfer and collagen-induced arthritis (CIA) models.

Main Results:

  • S100A9 - /- mice exhibited similar arthritis severity and histopathology compared to wild-type controls.
  • Defective expression of S100A8 and S100A9 did not alter disease progression in either arthritis model.

Conclusions:

  • S100A8 and S100A9 are not essential for the expression of inflammatory arthritis in the K/BxN serum transfer model.
  • S100A8 and S100A9 are not essential for the expression of inflammatory arthritis in the CIA model.
Abstract